Merck (MRK) stock in focus as its lung disease drug Winrevair gains FDA priority review for a label update based on Phase 3 ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

"Ligand has been an incredible partner over the past few years, and we look forward to their continued guidance and support ...

Elmiron (Regd) (pentosan polysulfate sodium), the only oral medication approved by the United States Food and Drug ...